Bristol-Myers Squibb Partners To Expand Diabetes Franchise In China
This article was originally published in PharmAsia News
Executive Summary
With Glucophage and Onglyza already on the market, BMS plans to launch more products in China through partnerships to gain a share of the world’s largest diabetes market.